Neuroprotection in Traumatic Brain Injury: Mesenchymal Stromal Cells can Potentially Overcome Some Limitations of Previous Clinical Trials
Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. In the last 30 years several neuroprotective agents, attenuating the downstream molecular and cellular damaging events triggered by TBI, have been extensively studied. Even though many drugs have shown promising resul...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | article |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.,
2018-10-01T00:00:00Z.
|
| Konular: | |
| Online Erişim: | Get full text Get full text |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|